‘Proven supplements for menopause’ is an appealing phrase and a poor scientific category. Vitamin D, creatine, magnesium and vitamin K2 do different jobs, have different evidence and are not interchangeable treatments for menopause.
The useful question is: proven for what outcome, in whom, at what dose, and compared with what? Correcting a documented deficiency is not the same as improving an outcome in someone whose intake or blood level is already adequate. A plausible biological mechanism is not proof that a supplement prevents fractures, fixes insomnia or improves day-to-day function.
IN THIS ARTICLE
- The evidence map
- Vitamin D: necessary does not mean limitless
- Creatine: the exercise partner with the clearest signal
- Magnesium: correct a gap, do not manufacture certainty
- K2: biologically interesting, not automatically required
- How to buy more safely in Canada
- The work and money cost of the supplement stack
- Sources and further reading
The evidence map
| Supplement | Best-supported use | What remains uncertain | Important caution |
|---|---|---|---|
| Vitamin D | Meeting recommended intake and correcting deficiency; one part of bone-health care | Higher doses in people who are already sufficient do not automatically prevent fractures or menopause symptoms | Excess can cause toxicity and high calcium; individual treatment may differ |
| Creatine monohydrate | Small additional strength and lean-mass gains when paired with resistance training in postmenopausal women | Bone-density and cognitive benefits remain uncertain; the supplement does not replace training | Discuss kidney disease, pregnancy and complex medical care |
| Magnesium | Meeting magnesium needs when intake is inadequate | Sleep trials are small and uncertain; menopause-specific benefit and superiority of one form are not established | Kidney disease, diarrhea and medication-absorption interactions |
| Vitamin K/K2 | Some trials report changes in bone markers or lumbar-spine density | Fracture results, routine use, formulation and dose remain uncertain; it is not standard Canadian menopause care | Potentially dangerous interaction with warfarin and similar anticoagulants |
Worth Reading
Optional broader reading—not evidence for a supplement claim.
Vitamin D: necessary does not mean limitless
Osteoporosis Canada’s 2023 guidance suggests a minimum 400 IU supplement daily alongside vitamin-D-rich foods, aiming for total intake of 600 IU/day for adults 51–70 and 800 IU/day after 70. That is general intake guidance—not a treatment dose for every person. Plans can differ for documented deficiency, malabsorption, osteoporosis treatment or other medical conditions. Megadosing without an indication is not a stronger version of prevention. For the larger Canadian screening and fracture-prevention picture, see Bone Health After 40.
Creatine: the exercise partner with the clearest signal
Creatine increases phosphocreatine availability for repeated high-intensity effort. A 2026 systematic review specific to postmenopausal women found small additional gains in lean mass and strength, particularly when at least 5 g/day was paired with resistance training; bone-density effects remained unclear. Creatine monohydrate is the form used in most of this research. That makes it the evidence reference—not proof that every woman needs it, or that a pricier “menopause blend” works better. Creatine complements training; it does not replace it. Readers working on muscle and nutrition can also use Protein After 40.
Worth Reading
Optional broader reading—not evidence for a supplement claim.
Magnesium: correct a gap, do not manufacture certainty
Magnesium is essential, but the insomnia story is ahead of the trials. A systematic review of older adults found only three small randomized trials and rated the evidence low to very low certainty. A broader review found associations between magnesium status and sleep in observational studies, while randomized-trial results remained uncertain. One encouraging trial of magnesium bisglycinate does not establish that form as superior or turn it into a universal menopause sleep treatment. Chronic insomnia still points first toward CBT-I and evaluation of hot flashes, sleep apnea, restless legs, mood, pain and medication; start with Why Am I Awake at 3 A.M.?. For stress and anxiety supplements specifically, see the separate evidence guide to supplements, teas and aromatherapy.
K2: biologically interesting, not automatically required
Vitamin K is required to activate proteins involved in blood clotting and bone biology. Meta-analyses of postmenopausal osteoporosis trials report possible improvements in some bone markers and lumbar-spine density, but results vary by formulation, dose and background treatment. Many trials were conducted in Japan, and pooled fracture results are sensitive to which studies are included. That is promising evidence, not a basis for routine K2 supplementation in every Canadian woman. Anyone taking warfarin or a similar vitamin-K antagonist needs consistent vitamin K intake and should not add K2 without the clinician managing that medication.
How to buy more safely in Canada
- Start with the outcome. ‘I want better sleep’ requires a different assessment from ‘my vitamin D is low.’
- Look for an eight-digit NPN. It identifies a natural health product licensed for sale in Canada for its labelled conditions of use. It does not prove strong menopause-specific evidence, validate extra claims made by a seller or show that the product is appropriate for you.
- Compare the active dose. For magnesium, read elemental magnesium; for blends, list every ingredient.
- Avoid proprietary stacks. They obscure dose and make side effects harder to trace.
- Run one change at a time with a defined outcome and stop date.
- Put supplements on the medication list. Pharmacists need to see them to identify interactions.
Worth Reading
Optional broader reading—not evidence for a supplement claim.
The work and money cost of the supplement stack
Women with fatigue, poor sleep or brain fog are easy targets for a monthly collection of bottles. The stack creates expense, scheduling burden and the belief that symptoms persist because the regimen is not yet perfect. Evidence-first care sometimes means buying nothing and redirecting that money to food, resistance training, CBT-I, physiotherapy or a clinical assessment.
Sources and further reading
- Osteoporosis Canada 2023 quick-reference guideline
- Osteoporosis Canada: Vitamin D
- Creatine plus resistance training in older females: systematic review and meta-analysis
- Creatine in postmenopausal women: systematic review and meta-analysis (2026)
- Magnesium for insomnia in older adults: systematic review and meta-analysis
- Magnesium and sleep: systematic review
- Vitamin K2 and postmenopausal osteoporosis: systematic review and meta-analysis
- Health Canada: natural health product regulation
Educational information only
This article is for education and does not diagnose, treat or replace care from a qualified health professional. Seek urgent care for severe or rapidly worsening symptoms.